Advertisement

Targeting Disease Modification in Psoriasis and Psoriatic Arthritis

Published on: 
, ,

Strategic Alliance Partnership | <b>Icahn School of Medicine at Mount Sinai</b>

Dermatologic experts explore strategies to slow the progression of psoriasis to psoriatic arthritis, offering evidence-based insights to optimize patient outcomes and enhance long-term disease management.

0:00 Overlap of PsO and PsA
4:00 Detecting Early PsA
13:20 Treatments for PsA
18:00 Defining Minimal Disease Activity
24:50 Biologics for PsA
31:00 Efficacy of IL-17i and IL-23i
37:00 Preventing Progression from PsO to PsA


Advertisement
Advertisement